Recent Press

1/10:	Emory and Virtually Better PTSD Experts to Train Armed Services Mental Health Clinicians
1/10:	Emory Will Partner with GlaxoSmithKline on Drug Research for Neglected Tropical Diseases
1/10:	Grady Testing Breakthrough for Traumatic Brain Injury
12/09:	Neuronetics NeuroStar TMS Theraphy^TM #5 Top Invention of 2009 by CNN
11/09:	Scientist on a Conveyor Belt of Discovery
10/09:	GeoVax Moving Headquarters to Smyrna
10/09:	Online H1N1 Flu Response Center Taps Emory Assessment Tool
9/09:	BHR Pharma Announces Phase III Study of Progesterone
8/09:	Alimera Sciences Closes $5 Million in Extended Series C Financing
7/09:	Gilead Sciences and Tibotec Pharmaceuticals to Develop New Fixed-Dose Combination of Truvada(R) and TMC278
6/09:	Emory Announces Phase III Study of Progesterone for Traumatic Brain Injury
6/09:	Technology Transfer Tools Drive Discovery and Protect Researchers
6/09:	NIH Grant Will Allow Nationwide Network to Study Effects of Hormone's Effectiveness
5/09:	Emory Starts Drug Discovery Center
5/09:	New Emory Institute for Drug Discovery Announced
5/09:	Emory, Australian Vaccine Centers Announce Alliance
5/09:	H1N1 Research Includes Monoclonal Antibodies, Virus-Like Particles, Virus Transmission Studies
5/09:	Sound Science: Todd Sherer - Technology Transfer Bringing Research to the People
5/09:	Johnson & Johnson Completes Aquisition of Cougar Biotechnology
5/09:	OTT 3rd Annual Celebration of Technology and Innovation, Marchl 31st
5/09:	Trail by Fire: New Antibody Method Gets Big Test
5/09:	Taking Biotechnology to the Market
5/09:	Lifesaving Science
4/09:	Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128
4/09:	Winship Cancer Institute Announces NCI Cancer Center Designation
3/09:	Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
2/09:	Emory OTT Ranked 16th Nationally in Licensing Revenue from Research Discoveries
1/09:	Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock

Previous Breaking News